Vaccinum febris dengue tetravalent (vivum, attenuatum)

Medicinal product name Dengvaxia
Pharmaceutical form Powder and solvent for suspension for injection
Strength  
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code J07BX Vaccines

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(0,5 ml)
Glass vial and pre-filled syringe    EU/1/18/1338/003  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/18/1338/003
Date of authorisation Dec 12, 2018
Marketing authorisation holder, country Sanofi Pasteur, France